MED

Medifast, Inc. NYSE

Consumer Cyclical ·Personal Products & Services ·US · medifastinc.com

$10.63

Mkt Cap $117.3M

52w Low $9.22 22.6% of range 52w High $15.46

50d MA $10.43 200d MA $11.97

P/E (TTM) -6.4x

EV/EBITDA -12.1x

P/B 0.6x

Debt/Equity 0.1x

ROE -9.4%

P/FCF 93.9x

RSI (14) —

ATR (14) —

Beta 0.56

50d MA $10.43

200d MA $11.97

Avg Volume 254.3K

About

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
May 4, 2026	AMC	-0.55	-0.19	+65.5%	—	—	—	—	—	—	—	—	—
Feb 17, 2026	AMC	-0.76	-0.55	+27.6%	10.80	-2.8%	-0.8%	-1.7%	-1.6%	-1.9%	-3.0%	-6.8%	—
Nov 3, 2025	AMC	-0.01	-0.21	-2000.0%	11.88	-3.5%	+0.8%	+2.5%	-0.7%	+0.4%	-0.8%	-7.3%	—
Aug 4, 2025	AMC	-0.30	0.04	+113.3%	13.51	+0.0%	-3.3%	-4.1%	-5.7%	-4.9%	-5.0%	+3.3%	—
Apr 28, 2025	AMC	-0.07	-0.11	-57.1%	12.58	-4.4%	-0.6%	+4.5%	+3.2%	+5.3%	+4.1%	+7.2%	—
Feb 18, 2025	AMC	-0.16	0.10	+162.5%	16.13	-2.0%	-11.4%	-11.2%	-8.7%	-8.4%	-10.8%	-11.0%	—
Nov 4, 2024	AMC	-0.15	0.35	+333.3%	18.81	+10.6%	+8.5%	+4.7%	+5.7%	+1.9%	+3.3%	+4.9%	—
Aug 5, 2024	AMC	0.36	0.92	+155.6%	20.86	-6.5%	-2.8%	-4.6%	-5.3%	-6.4%	-7.4%	-9.2%	—
Apr 29, 2024	AMC	0.78	0.66	-15.4%	35.51	-25.1%	-22.5%	-25.8%	-27.0%	-24.8%	-29.1%	-29.2%	—
Feb 20, 2024	AMC	0.99	1.09	+10.1%	48.93	-9.1%	-17.5%	-18.3%	-16.8%	-17.1%	-14.7%	-27.2%	—
Nov 6, 2023	AMC	1.07	2.12	+98.1%	70.66	-2.2%	-2.5%	-6.7%	-8.2%	-7.4%	-12.0%	+2.2%	—
Aug 7, 2023	AMC	1.44	2.77	+92.4%	96.09	+4.1%	-6.9%	-3.5%	-4.8%	-2.3%	-3.8%	-16.2%	—
May 1, 2023	AMC	2.40	3.67	+52.9%	90.57	-6.4%	-2.7%	-5.9%	-2.7%	+0.4%	-1.0%	-13.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 19	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$10.71	$10.50	-2.0%	-0.8%	-0.7%	-1.0%	-2.1%	-0.6%
Feb 19	DA Davidson	Maintains	Neutral → Neutral	—	$16.13	$15.80	-2.0%	-11.4%	-11.2%	-8.7%	-8.4%	-10.8%
Nov 5	DA Davidson	Upgrade	Underperform → Neutral	—	$18.81	$20.80	+10.6%	+8.5%	+4.7%	+5.7%	+1.9%	+3.3%
Jul 22	DA Davidson	Maintains	Underperform → Underperform	—	$18.64	$18.81	+0.9%	+1.4%	+0.5%	+1.1%	+4.8%	+9.9%
Jun 5	DA Davidson	Downgrade	Neutral → Underperform	—	$23.97	$20.43	-14.8%	-8.1%	-8.8%	-10.5%	-12.2%	-10.4%
Apr 30	DA Davidson	Maintains	Neutral → Neutral	—	$35.51	$26.60	-25.1%	-22.5%	-25.8%	-27.0%	-24.8%	-29.1%
Feb 21	DA Davidson	Maintains	Neutral → Neutral	—	$48.93	$44.49	-9.1%	-17.5%	-18.3%	-16.8%	-17.1%	-14.7%
Aug 8	DA Davidson	Maintains	Neutral → Neutral	—	$96.09	$100.00	+4.1%	-6.9%	-3.5%	-4.8%	-2.3%	-3.8%
Jul 31	DA Davidson	Maintains	Neutral → Neutral	—	$107.06	$107.40	+0.3%	-4.8%	-6.7%	-5.4%	-6.3%	-7.7%
May 2	DA Davidson	Maintains	Neutral → Neutral	—	$90.57	$84.77	-6.4%	-2.7%	-5.9%	-2.7%	+0.4%	-1.0%
Feb 22	DA Davidson	Maintains	Neutral → Neutral	—	$105.44	$101.10	-4.1%	-2.4%	+3.0%	+4.3%	+6.0%	+6.3%
Nov 4	DA Davidson	Downgrade	Buy → Neutral	—	$103.38	$96.37	-6.8%	+4.1%	+3.4%	+5.9%	+0.9%	+11.1%
Aug 4	Jefferies	Downgrade	Buy → Hold	—	$171.60	$150.54	-12.3%	-13.7%	-19.1%	-20.5%	-26.6%	-25.1%
Aug 4	DA Davidson	Maintains	Buy → Buy	—	$171.60	$150.54	-12.3%	-13.7%	-19.1%	-20.5%	-26.6%	-25.1%
Jun 2	DA Davidson	Maintains	Buy → Buy	—	$174.81	$180.36	+3.2%	+8.4%	+5.4%	+5.4%	+8.4%	+8.4%
Feb 24	DA Davidson	Maintains	Buy → Buy	—	$176.16	$169.56	-3.7%	-2.0%	+1.1%	+5.6%	+9.4%	+9.2%
Nov 8	DA Davidson	Maintains	Buy → Buy	—	$222.19	$222.20	+0.0%	-1.1%	+0.9%	+0.3%	+2.8%	+2.3%
May 5	DA Davidson	Maintains	Buy → Buy	—	$225.00	$248.78	+10.6%	+12.1%	+18.7%	+23.7%	+31.0%	+30.8%
Feb 26	DA Davidson	Maintains	Buy → Buy	—	$254.75	$250.35	-1.7%	-0.7%	+4.3%	+2.6%	-0.1%	-5.9%
Jan 25	Jefferies	Upgrade	Hold → Buy	—	$220.87	$227.34	+2.9%	+8.7%	+10.0%	+8.9%	+7.6%	+6.2%
Jan 12	DA Davidson	Maintains	Buy → Buy	—	$207.43	$208.00	+0.3%	+0.6%	+3.0%	+4.0%	+0.5%	+7.0%
Nov 5	DA Davidson	Upgrade	Neutral → Buy	—	$160.90	$167.73	+4.2%	+4.7%	+7.8%	-0.5%	+1.4%	+5.7%
Jun 25	B. Riley FBR	Maintains	Buy → Buy	—	$123.01	$124.68	+1.4%	+6.5%	+7.0%	+11.0%	+12.8%	+14.8%
May 6	DA Davidson	Maintains	Neutral → Neutral	—	$75.33	$82.86	+10.0%	+15.6%	+21.9%	+26.9%	+20.2%	+15.5%
Feb 27	DA Davidson	Maintains	Neutral → Neutral	—	$94.48	$81.11	-14.2%	-9.2%	-12.0%	-12.9%	-14.2%	-12.7%
Nov 8	DA Davidson	Downgrade	Buy → Neutral	—	$102.00	$67.00	-34.3%	-27.1%	-21.0%	-21.7%	-21.6%	-24.9%
Jul 25	Jefferies	Maintains	Buy → Buy	—	$113.22	$114.36	+1.0%	+1.5%	+1.2%	-0.2%	-1.1%	-1.4%
Feb 27	Sidoti & Co.	Maintains	Buy → Buy	—	$131.72	$141.00	+7.0%	-2.3%	-3.3%	-3.9%	-2.3%	+0.8%
Nov 8	Sidoti & Co.	Upgrade	Neutral → Buy	—	$153.31	$156.98	+2.4%	+0.8%	+4.3%	+3.0%	+5.7%	+2.1%
May 24	DA Davidson	Maintains	Buy → Buy	—	$136.80	$138.98	+1.6%	+3.0%	+2.8%	+5.1%	+6.9%	+7.1%
Apr 19	Sidoti & Co.	Downgrade	Buy → Neutral	—	$102.84	$102.11	-0.7%	-5.6%	-3.8%	-4.7%	-3.0%	-2.9%
Sep 15	DA Davidson	Maintains	Buy → Buy	—	$54.82	$56.00	+2.2%	+3.0%	+6.1%	+5.2%	+4.9%	+2.5%
Aug 17	DA Davidson	Maintains	Buy → Buy	—	$51.63	$51.98	+0.7%	+8.0%	+8.1%	+7.7%	+7.9%	+7.0%
Jan 29	Wunderlich	Maintains	Hold → Hold	—	$28.68	$28.42	-0.9%	+1.2%	+0.4%	+0.7%	-2.5%	-3.5%
Nov 30	Sidoti & Co.	Downgrade	Buy → Neutral	—	$31.84	$30.85	-3.1%	-4.8%	-5.7%	-4.7%	-6.1%	-6.2%
Oct 5	Sidoti & Co.	Upgrade	Neutral → Buy	—	$27.02	$28.03	+3.7%	+7.3%	+4.2%	+7.0%	+6.9%	+6.8%
Mar 3	BofA Securities	Downgrade	Neutral → Underperform	—	$32.35	$32.11	-0.7%	-1.3%	-1.2%	-3.2%	-3.2%	-3.5%
Mar 3	Bank of America	Downgrade	Neutral → Underperform	—	$32.35	$32.11	-0.7%	-1.3%	-1.2%	-3.2%	-3.2%	-3.5%
Nov 7	Imperial Capital	Downgrade	Outperform → In Line	—	$32.81	$30.58	-6.8%	-9.3%	-8.7%	-10.0%	-8.2%	-9.2%
Nov 6	Canaccord Genuity	Maintains	Hold → Hold	—	$30.09	$31.26	+3.9%	+9.0%	-1.1%	-0.4%	-1.8%	+0.1%
Aug 11	Imperial Capital	Maintains	Outperform → Outperform	—	$26.15	$26.24	+0.3%	+2.8%	+0.4%	+0.7%	+2.9%	+3.7%
Jun 12	Canaccord Genuity	Maintains	Hold → Hold	—	$32.26	$32.43	+0.5%	+2.0%	+5.4%	+5.6%	+4.3%	+2.9%
Apr 23	Imperial Capital	Maintains	Outperform → Outperform	—	$32.77	$32.90	+0.4%	-1.3%	-0.5%	-3.3%	-3.9%	-4.2%
Sep 6	Imperial Capital	Maintains	Outperform → Outperform	—	$25.77	$26.24	+1.8%	-1.0%	+1.5%	+0.7%	+0.0%	+1.2%
Mar 26	Wedbush	Maintains	Outperform → Outperform	—	$22.64	$22.64	+0.0%	-0.9%	-1.2%	+1.2%	-1.8%	+2.1%
Dec 19	Canaccord Genuity	Maintains	Hold → Hold	—	$31.25	$31.57	+1.0%	+1.5%	+2.2%	-5.0%	-6.0%	-18.4%
Dec 19	Wedbush	Maintains	Outperform → Outperform	—	$31.25	$31.57	+1.0%	+1.5%	+2.2%	-5.0%	-6.0%	-18.4%
Aug 20	Wedbush	Maintains	Outperform → Outperform	—	$28.87	$28.86	-0.0%	-1.2%	-3.0%	-2.0%	-3.3%	-2.4%
May 9	Sidoti & Co.	Upgrade	Neutral → Buy	—	$17.87	$15.56	-12.9%	-6.5%	-2.7%	+1.7%	+1.8%	+1.7%
May 9	Wedbush	Maintains	Outperform → Outperform	—	$17.87	$15.56	-12.9%	-6.5%	-2.7%	+1.7%	+1.8%	+1.7%

Recent Filings

8-K · 2.02 !! High

Medifast, Inc. -- 8-K 2.02: Earnings Results

Medifast reported first-quarter 2026 earnings results, providing investors with an update on the company's operational performance and financial condition for the period ending March 31, 2026.

May 4

8-K · 5.02 !!! Very High

Unknown — 8-K 5.02: Executive Change

New leadership at MED could signal strategic shifts in operations and capital allocation, making it crucial for investors to assess whether the replacement strengthens or weakens management quality.

Mar 20

8-K

Medifast, Inc. -- 8-K Filing

Medifast's return to positive coach productivity growth in Q4 2025 signals potential recovery momentum, as this metric historically precedes broader business improvement for the direct-sales wellness company.

Feb 17

Data updated apr 26, 2026 11:47am · Source: massive.com